Hit ‘enter’ to search full site for “Search query”
Read our recent announcements about our company, our research, and partnerships.
BlinkLab presents at the TechKnow Invest Roadshow 2026 in Sydney and Melbourne, Australia
U.S. Patent Granted for Remote Neurobehavioural Testing Platform
BlinkLab's Chairman, Mr Brian Leedman presented at the Stocks in the Vines – Investor Access Day in the Yarra Valley, Victoria.
BlinkLab presents at international investment events as part of its ongoing engagement with professional and sophisticated investors throughout the Asia-Pacific region.
BlinkLab successfully completes an oversubscribed placement new shares to sophisticated and institutional investors; raising a total of A$17.5 million (before costs).
BlinkLab announced the commencement of its validation program supporting 510(k) submission, with the first child participant now enrolled and having completed initial testing using BlinkLab Dx1.
BlinkLab announces its involvement in a landmark national autism screening and capacity-building initiative launched by the Kingdom of Morocco.
BlinkLab announces the onboarding of University of Arkansas as the tenth and final clinical site for the Company’s upcoming pivotal U.S. regulatory trial for BlinkLab Dx 1.
Formation of new partnership with the SHANK2 Foundation, a U.S.-based not-for-profit organisation with a focus on advocacy, awareness, the creation of research infrastructure.
.png)
